Recuren Plus Balanced Scalp

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Recuren Plus Balanced Scalp
Generic name: SALICYLIC ACID
Manufacturer: REGENEREN PLUS LTD
Product type: HUMAN OTC DRUG
SPL set ID: 50c27b0f-9bf5-de9c-e063-6394a90af41a
SPL ID: 50c27b0f-9bf6-de9c-e063-6394a90af41a
Version: 1
Effective date: 2026-05-04
Source export date: 2026-09-28
Source partition: 14
Source file: https://download.open.fda.gov/drug/label/drug-label-0014-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-09-28/db99fd80353afecef4949b48edcaa018be72b966b2360184251eb14df43743f9/drug-label-0014-of-0014.json.zip
Source manifest SHA-256: cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run: 20260929T050834Z
Imported at: 2026-09-29 06:39:41

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 11 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M032	openfda.application_number
brand name		Recuren Plus Balanced Scalp	openfda.brand_name
generic name		SALICYLIC ACID	openfda.generic_name
manufacturer name		REGENEREN PLUS LTD	openfda.manufacturer_name
ndc	package	87014-006-01	openfda.package_ndc
ndc	product	87014-006	openfda.product_ndc
ndc11	package	87014000601	derived:openfda.package_ndc
rxcui		205173	openfda.rxcui
spl id		50c27b0f-9bf6-de9c-e063-6394a90af41a	id
spl set id		50c27b0f-9bf5-de9c-e063-6394a90af41a	set_id
unii		O414PZ4LPZ	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

For external use only. Do not use on children under 2 years of age unless directed by a doctor. Avoid contact with eyes. If contact occurs, rinse eyes thoroughly with water. If condition worsens or does not improve after regular use as directed. Before use if you have a condition that covers a large area of the body. If swallowed, get medical help or contact a Poison Control Center right away.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.